Bergman Clinics has acquired MohsA Huidcentrum to enhance its dermatological care offerings in the Netherlands, emphasizing a shared commitment to high-quality medical services.
Target Information
MohsA Huidcentrum is an independent treatment center specializing in the management of skin cancer and other dermatological conditions. The clinic is committed to advancing its expertise in diagnosing and treating various skin disorders, operating facilities in Eindhoven, Venray, and Bladel. MohsA Huidcentrum collaborates closely with several university hospitals in the region and employs a large team of specialists, including dermatologists, medical assistants, nurses, and skin therapists, all focused on providing pain-free surgical procedures and treatments.
In addition to its top-tier cancer care, MohsA offers general dermatological services, including eczema treatments, varicose vein treatments, and skin therapy. This comprehensive range of services positions MohsA as a leader in the dermatology field within the Netherlands.
Access Full Deal Insights
You’re viewing a public preview of this deal. To unlock full access to ca. 50,000 other deals in our database and join ca. 400 M&A professionals who are using it daily, sign up for Dealert.
Industry Overview
The healthcare industry in the Netherlands has experienced significant transformations in recent years, particularly in the area of planned medical care. With a growing emphasis on patient-centric services, healthcare providers are
Similar Deals
Xpert Clinics → Parkwegkliniek Sommer
2025
Bergman Clinics
invested in
MohsA Huidcentrum
in 2024
in a Merger deal